Clinical Study
Is Type 2 Diabetes Really Resolved after Laparoscopic Sleeve Gastrectomy? Glucose Variability Studied by Continuous Glucose Monitoring
Table 3
Differences between group A and group B regarding age, BMI, insulin therapy, A1c, C-peptide, diabetes duration, and weight loss.
| | | Group A | Group B | |
| | Age (years) | 48.4 ± 8.2 | 52.0 ± 8.5 | 0.02 | | Preoperative BMI (kg/m2) | 45.1 ± 7.2 | 42.8 ± 7.4 | 0.04 | | Insulin use (number of patients) | 0/8 | 3/12 | — | | A1c before surgery (%) | 7.5 ± 1.0 | 7.4 ± 1.0 | — | | C-peptide before surgery (ng/mL) | 5.2 ± 1.5 | 3 ± 0.5 | 0.02 | | Diabetes duration before surgery (years) | 2.5 ± 2.3 | 6.5 ± 4.5 | 0.04 | | Total weight loss after surgery (%) | 33.7 ± 13.9 | 31.6 ± 11.8 | — | | EWL after surgery (%) | 63.8 ± 26.3 | 69.1 ± 16.8 | — |
|
|
